Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patientsSONIS, Stephen T; ELTING, Linda S; KEEFE, Dorothy et al.Cancer. 2004, Vol 100, Num 9, pp 1995-2025, issn 0008-543X, 31 p., SUPArticle

A multinational, randomized phase III trial of iseganan hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyTROTTI, Andy; GARDEN, Adam; ROSENTHAL, David I et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 674-681, issn 0360-3016, 8 p.Article

Mucositis in the treatment of haematological malignanciesNISCOLA, P; SCARAMUCCI, L; GIOVANNINI, M et al.GIOVANNINI, M et al.Annals of oncology. 2008, Vol 19, issn 0923-7534, vii141-vii145, SUP7Article

Diagnosis and management of peri-implant diseasesHEITZ-MAYFIELD, L. J. A.Australian Dental Journal. 2008, Vol 53, issn 0045-0421, S43-S48, SUP1Article

Prise en charge de la muciteTABRIZI, R.Hématologie (Montrouge). 2011, Vol 17, pp 20-22, issn 1264-7527, 3 p., SUP3Conference Paper

Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancyWILLNER, Nadav; STORCH, Shimon; TADMOR, Tamar et al.European journal of clinical pharmacology. 2014, Vol 70, Num 3, pp 261-263, issn 0031-6970, 3 p.Article

Reliability and construct validity of the oral mucositis daily questionnaire in children with cancerTOMLINSON, Deborah; ETHIER, Marie-Chantal; JUDD, Peter et al.European journal of cancer (1990). 2011, Vol 47, Num 3, pp 383-388, issn 0959-8049, 6 p.Article

Mucositis pain induced by radiation therapy : Prevalence, severity, and use of self-care behaviorsWONG, Piera C; DODD, Marylin J; MIASKOWSKI, Christine et al.Journal of pain and symptom management. 2006, Vol 32, Num 1, pp 27-37, issn 0885-3924, 11 p.Article

Barriers and strategies in implementation of oral care standards for cancer patientsMCGUIRE, Deborah B.Supportive care in cancer. 2003, Vol 11, Num 7, pp 435-441, issn 0941-4355, 7 p.Article

Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?AL-DASOOQI, Noor; GIBSON, Rachel J; BOWEN, Joanne M et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 1, pp 1-9, issn 0344-5704, 9 p.Article

Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal?WARDILL, Hannah R; BOWEN, Joanne M; GIBSON, Rachel J et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 5, pp 627-635, issn 0344-5704, 9 p.Article

Preliminary Characterization of Oral Lesions Associated With Inhibitors of Mammalian Target of Rapamycin in Cancer PatientsSONIS, Stephen; TREISTER, Nathaniel; CHAWLA, Sant et al.Cancer. 2010, Vol 116, Num 1, pp 210-215, issn 0008-543X, 6 p.Article

Updated clinical practice guidelines for the prevention and treatment of mucositisKEEFE, Dorothy M; SCHUBERT, Mark M; ELTING, Linda S et al.Cancer. 2007, Vol 109, Num 5, pp 820-831, issn 0008-543X, 12 p.Article

Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology GroupSENCER, S. F; ZHOU, T; JONAS, W. B et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 11, pp 1409-1414, issn 0268-3369, 6 p.Article

Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositisALAMIR, I; BOUKHETTALA, N; AZIZ, M et al.Clinical and experimental immunology (Print). 2010, Vol 162, Num 2, pp 298-305, issn 0009-9104, 8 p.Article

Effectiveness of Topical Administration of Opioids in Palliative Care: A Systematic ReviewLEBON, Beata; ZEPPETELLA, Giovambattista; HIGGINSON, Irene J et al.Journal of pain and symptom management. 2009, Vol 37, Num 5, pp 913-917, issn 0885-3924, 5 p.Article

Oral mucosal injury caused by cancer therapies: current management and new frontiers in researchJENSEN, Siri B; PETERSON, Douglas E.Journal of oral pathology & medicine. 2014, Vol 43, Num 2, pp 81-90, issn 0904-2512, 10 p.Article

Mucites orales liées aux traitements anticancéreux : prévention = Oral mucositis induced by antineoplastic agents: preventionLa Revue Prescrire. 2011, Vol 31, Num 333, pp 532-533, issn 0247-7750, 2 p.Article

A randomized controlled trial of visible-light therapy for the prevention of oral mucositisELAD, Sharon; LUBOSHITZ-SHON, Noa; COHEN, Tehila et al.Oral oncology (1997). 2011, Vol 47, Num 2, pp 125-130, issn 1368-8375, 6 p.Article

Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapyBOWEN, Joanne M; GIBSON, Rachel J; TSYKIN, Anna et al.International journal of cancer. 2007, Vol 121, Num 8, pp 1847-1856, issn 0020-7136, 10 p.Article

Systemic antibiotics and debridement of peri-implant mucositis. A randomized clinical trialHALLSTRÖM, Hadar; RUTGER PERSSON, G; LINDGREN, Susann et al.Journal of clinical periodontology. 2012, Vol 39, Num 6, pp 574-581, issn 0303-6979, 8 p.Article

Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositisSARMATI, Loredana; BELTRAME, Angela; AMADORI, Sergio et al.American journal of hematology. 2010, Vol 85, Num 5, pp 380-383, issn 0361-8609, 4 p.Article

Clinical assessment and management of the oral environment in the oncology patientWALSH, L. J.Australian dental journal. 2010, Vol 55, pp 66-77, issn 0045-0421, 12 p., SUP1Article

Peri-implant diseases : diagnosis and risk indicatorsHEITZ-MAYFIELD, Lisa J. A.Journal of clinical periodontology. 2008, Vol 35, pp 292-304, issn 0303-6979, 13 p., SUP8Conference Paper

Impact on cytoprotective efficacy of intermediate interval between amifostine administration and radiotherapy: A retrospective analysisKOULOULIAS, Vassilios E; KOUVARIS, John R; KOKAKIS, John D et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 4, pp 1148-1156, issn 0360-3016, 9 p.Article